CAMP4 Therapeutics is a biotechnology company. It offers Gene Circuitry Platform, an approach capable of mapping the transcriptional machinery and network of signaling pathways that control gene expression across cells in the human body.
Type | Private | |
Founded | 2016 | |
HQ | Cambridge, MA, US | Map |
Website | camp4tx.com |
Employees (est.) (Jun 2022) | 61 | (+2%) |
Cybersecurity rating | A | More |
Founding Date | 2016 |
CAMP4 Therapeutics total Funding | $30 m |
CAMP4 Therapeutics latest funding size | $30 m |
Time since last funding | 4 years ago |
CAMP4 Therapeutics investors | Andreessen Horowitz, Polaris Partners, The Kraft Group |
When was CAMP4 Therapeutics founded?
CAMP4 Therapeutics was founded in 2016.
Who are CAMP4 Therapeutics key executives?
CAMP4 Therapeutics's key executives are Josh Mandel-Brehm, Jorge Conde and David Bumcrot.
How many employees does CAMP4 Therapeutics have?
CAMP4 Therapeutics has 61 employees.
Who are CAMP4 Therapeutics competitors?
Competitors of CAMP4 Therapeutics include Oxford BioTherapeutics, MicrofluidX and Affinia Therapeutics.
Where is CAMP4 Therapeutics headquarters?
CAMP4 Therapeutics headquarters is located at One Kendall Square, Binney St, Cambridge.
Where are CAMP4 Therapeutics offices?
CAMP4 Therapeutics has an office in Cambridge.
How many offices does CAMP4 Therapeutics have?
CAMP4 Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies